The third dose of the coronavirus vaccine significantly increases the antibody levels in the body of cancer patients.
This is evidenced by the results of a study conducted in the oncology department of the Ichilov hospital. The results are published in the Lancet Oncology.
According to scientists, more than 6 months after receiving the first two doses, antibody levels decline. Healthy patients and about 20% of cancer patients do not have antibodies after six months.
And the introduction of the third dose helps to significantly increase their levels. Most patients develop a positive immune response without significant side effects.